This inventor holds 4 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1981-1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Frankfurt-am-Main, DE (1981 - 1982)
- Schwalbach, DE (1987)
Company Filing History:
Years Active: 1981-1987
Title: **Michael Molter: A Pioneer of Diagnostic Innovations**
Introduction
Michael Molter, an accomplished inventor based in Frankfurt am Main, Germany, has made significant contributions to the field of medical diagnostics. With a portfolio that includes four patents, Molter’s work focuses on the development of advanced diagnostic agents that aid in visualizing critical bodily systems.
Latest Patents
Among his latest patents, Michael Molter has developed a groundbreaking diagnostic agent utilizing Technetium-99m triphosphonates and tetraphosphonates. This invention serves as a diagnostic aid for the visualization of organs containing the reticuloendothelial system (RES) and lymph vessels. The patent outlines the use of these compounds in physiologic saline and includes a detailed process for their preparation.
Additionally, he has created substituted acetanilidoiminodiacetic acid compounds, which function as diagnostic agents for the heptobiliary system. The compounds, such as (2,3,4,5,6-pentafluoroacetanilido)-iminodiacetic acid, and (4-n-pentylacetanilido)-iminodiacetic acid, can be synthesized from chloroacetic acid derivatives. These innovative diagnostic agents, once labeled with Technetium-99m, play a crucial role in medical imaging.
Career Highlights
Michael Molter is currently affiliated with Hoechst Aktiengesellschaft, a prominent company known for its scientific contributions and advancements in healthcare. His research and innovations have positioned him as a key player in the field of medical diagnostics, where his inventions are poised to improve diagnostic accuracy and patient care.
Collaborations
Throughout his career, Molter has collaborated with esteemed colleagues, including Gerhard Kloss and Eberhard Schickel. Together, they have worked on innovative projects that bridge chemistry and medicine, furthering the capabilities of diagnostic imaging.
Conclusion
Michael Molter’s dedication to innovation in medical diagnostics is evidenced by his impressive patent portfolio. His work not only enhances the understanding of complex biological systems but also significantly impacts clinical practices. As advancements in medical technology continue, inventors like Molter are crucial to shaping the future of healthcare diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile